Standard screening test: NONE

Pelvic ultrasound and CA125 can be used, but have not been shown to reduce mortality. Limited sensitivity and specificity.

Known risk factors

  • Family history of ovarian cancer.
  • BRCA gene mutations, Lynch syndrome, nulliparity.
  • Family history of breast cancer (possibly colorectal, uterine or pancreatic cancer).
  • Personal history of breast cancer.
  • Ashkenazi Jewish ancestry.
  • Hormone replacement therapy.
  • Smoking.
  • Asbestos exposure.

Additional facts & information:

5 Year Survival

  • Stage 0 – no data
  • Stages 1&2 – 92%
  • Stage 3 – 73%
  • Stage 4 – 29%

About 79% of cases are diagnosed late at stage 3 or stage 4.